Singapore markets close in 1 hour 46 minutes
  • Straits Times Index

    3,241.24
    +15.79 (+0.49%)
     
  • Nikkei

    27,574.43
    -111.97 (-0.40%)
     
  • Hang Seng

    19,424.01
    +609.19 (+3.24%)
     
  • FTSE 100

    7,489.19
    -32.20 (-0.43%)
     
  • BTC-USD

    16,829.08
    -110.45 (-0.65%)
     
  • CMC Crypto 200

    394.98
    -7.05 (-1.75%)
     
  • S&P 500

    3,933.92
    -7.34 (-0.19%)
     
  • Dow

    33,597.92
    +1.58 (+0.00%)
     
  • Nasdaq

    10,958.55
    -56.34 (-0.51%)
     
  • Gold

    1,797.10
    -0.90 (-0.05%)
     
  • Crude Oil

    72.99
    +0.98 (+1.36%)
     
  • 10-Yr Bond

    3.4080
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,463.44
    -3.44 (-0.23%)
     
  • Jakarta Composite Index

    6,797.43
    -21.32 (-0.31%)
     
  • PSE Index

    6,525.16
    -149.22 (-2.24%)
     

Where Will AbbVie Be in 3 Years?

Where Will AbbVie Be in 3 Years?

In spite of market turmoil, this year has been bright so far for AbbVie (NYSE: ABBV). The company's star drug Humira continues to grow, and even reached the milestone of more than $20 billion in sales last year. Its other immunology drugs and the neuroscience business also are thriving.